ZOLL Sudden Cardiac Death Risk and Prevention

Cath Lab
Assess SCD Risk
Post-PCI and Post-MI
Clinical studies, SCD
risk screening tools,
interactive patient case studies

Patient Consult
Discuss SCD Risk
Resources to educate your
patients about their SCD risk

Library
Access All Resources
A destination page
for all of the resources
on the site

Heart Failure Clinic
Clinical studies,
risk during medical
optimization

Close
      Sources  >>    
How many high-risk post-PCI patients die during recovery? Test your knowledge about SCD >> Watch Now >>

Screening & Risk Tools
Assess SCD Risk
SCD Risk Calculator App
SCD Screening Protocol
CADILLAC Risk Score
ACS HF Treatment Algorithm
Interactive Infographic

   Clinical Studies   
Wealth of Evidence
CADILLAC (Halkin, JACC)
Post-MI SCD (Adabag, JAMA)
VALIANT Trial (Solomon, NEJM)
Post-Revascularization Mortality
(Zishiri, Circulation)
Predict Post-PCI Mortality
(Weintraub, Circulation)

What do you know
about SCD?
Challenge your Sudden
Cardiac Death knowledge.
All of the answers can be
found on this website.

      Patient Case Studies     
Managing SCD Risk
39 yo Male, Post-PCI, Acute MI
59 yo Male, Post-PCI, obese, COPD
60 yo Female, Post-PCI, diabetic
68 yo Male, Post-PCI,
100% occluded STEMI
45 yo Male, STEMI,
multi-vessel disease

Education
Talking to Patients
How to Communicate the
Risk of SCA to Patients
(free Medscape login required)

Back To Reception

Support Tools
for Patient Conversations
Sudden Cardiac Arrest
Conversation Tool
Sudden Cardiac Arrest:
It’s Not a Heart Attack
(Resource for Patients)

Close
      Sources  >>    

Clinical Studies
Wealth of Evidence
CADILLAC (Halkin, JACC)
Post-MI SCD (Adabag, JAMA)
VALIANT Trial (Solomon, NEJM)
Post-Revascularization Mortality
(Zishiri, Circulation)
Predict Post-PCI Mortality
(Weintraub, Circulation)

      Patient Case Studies     
Managing SCD Risk
39 yo Male, Post-PCI, Acute MI
59 yo Male, Post-PCI, obese, COPD
60 yo Female, Post-PCI, diabetic
68 yo Male, Post-PCI,
100% occluded STEMI
45 yo Male, STEMI,
multi-vessel disease

Screening & Risk Tools
Assess SCD Risk
SCD Risk Calculator App
SCD Screening Protocol
CADILLAC Risk Score
ACS HF Treatment Algorithm
Interactive Infographic

Back To Reception

Close
      Sources  >>    

Clinical Studies
Wealth of Evidence
Post-MI SCD (Adabag, JAMA)
VALIANT Trial (Solomon, NEJM)
Medical Optimization
(MERIT-HF, The Lancet)

Screening & Risk Tools
Assess SCD Risk
SCD Screening Protocol
ACS HF Treatment Algorithm
Interactive Infographic

Back To Reception

Close
      Sources  >>    
Close

     Education    
Talking to Patients
How to Communicate the
Risk of SCA to Patients
(free Medscape login required)

Support Tools
for Patient Conversations
Sudden Cardiac Arrest
Conversation Tool
Sudden Cardiac Arrest:
It’s Not a Heart Attack
(Resource for Patients)

Back To Reception

       Sources  >>    
Cath Lab
Here you can find a variety of materials about SCD risk post-PCI and post-MI. Download SCD risk screening tools, review relevant clinical studies or learn more about SCD risk assessment with interactive patient case studies.
CADILLAC Risk Score
SCD Risk Calculator App
Click the appropriate icon below to download the SCD Risk Calculator for your device:
iPhone
Android
ACS HF Treatment Algorithm

SCD Screening Protocol

Interactive Infographic
VALIANT Trial (Solomon, NEJM)

Post-MI SCD (Adabag, JAMA)

CADILLAC (Halkin, JACC)

Predict Post-PCI Mortality (Weintraub, Circulation)

Post-Revascularization Mortality (Zishiri, Circulation)

39 yo Male, Post-PCI, low EF
59 yo Male, Post-PCI, obese
60 yo Female, Post-PCI, diabetic
68 yo Male, post-PCI, 100% STEMI
45 yo Male, post-MI, low EF
1 Halkin, A et al. Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: CADILLAC Risk Score. JACC 2005;45:1397–1405.
2 Adabag AS et al. Sudden Death After Myocardial Infarction. JAMA 2008;300:2022–2029.
3 Solomon SD et al. Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. NEJM 2005;352:2581–2588.
4 Zishiri ET et al. Early Risk of Mortality after Coronary Artery Revascularization in Patients with Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator. Circulation: Arrhythmia and Electrophysiology.2013;6: 117–128.
5 Weintraub et al. Prediction of Long-Term Mortality After Percutaneous Coronary Intervention in Older Adults: Results From the National Cardiovascular Data Registry. Circulation: 2012;125:1501–1510.
6 Stone, G et al. Prevention of Sudden Cardiac Arrest Post PTCA in High-Risk Patients. http://www.theheart.org/article/1202823.do (April 2011).
7 Al-Khatib SM et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. J Am Coll Cardiol 2017, doi: 10.1016/j.jack.2017.10.054.
8 Olgin JE, Pletcher MJ, Vittinghoff E, et al. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med. 2018;379(13):1205–1215.
50-60% of mortality during post-PCI/post-MI recovery is due to SCD (EF≤35%)6,8 Despite PCI and GDMT, 1 in 20 post-MI (EF<35%) patients die in the first 90 days8 Following an MI, risk of SCD is highest in the first 90 days3

Use this infographic to support discussion
with your patients about their SCA risk

Take Home Resource For Patients

CADILLAC (Halkin, JACC)

Benefits of Medical Optimization
Take Time

SCA Conversation Tool Order Form



* Indicates required fields
Contact information will be used only for the purposes of delivering your shipment. It will not be used for any promotional purposes.
Submit
What's your SCDIQ?
Sudden Cardiac Death (SCD) is a leading cause of death in the early period post-MI. Learn more about factors that increase this risk: